Press release
Competitive Analysis: Leading Companies and New Entrants in the Messenger Ribonucleic Acid Quality Monitoring Market
Messenger Ribonucleic Acid Quality Monitoring Market
Projected Market Value and Growth Trajectory of the Messenger Ribonucleic Acid Quality Monitoring Market
The market for messenger ribonucleic acid quality monitoring is anticipated to grow substantially, reaching a valuation of $2.25 billion by 2029. This expansion corresponds to a compound annual growth rate (CAGR) of 11.1%. Factors contributing to this upswing include the rising production of mRNA therapeutics, increased investment in biomanufacturing infrastructure, heightened demand for rigorous quality assurance of RNA-based products, broader applications of mRNA in personalized medicine, and the rising adoption of automated testing technologies. Key trends projected to influence the market over the forecast period involve the development of highly sensitive assays, integration of cloud-based monitoring platforms, advancements in non-invasive detection methods, creation of multiplexed quality assessment systems, and combining high-throughput sequencing with quality control processes.
Download a free sample of the messenger ribonucleic acid quality monitoring market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=30321&type=smp
Key Factors Propelling Growth in the Messenger Ribonucleic Acid Quality Monitoring Market
The growing production of messenger ribonucleic acid therapeutics is a primary driver boosting market expansion. As mRNA-based treatments become more prevalent in tackling various diseases, the need to ensure consistent quality and efficacy intensifies, fueling demand for robust monitoring solutions.
Additionally, increasing investments in biomanufacturing infrastructure are supporting this growth. Enhanced facilities enable large-scale production of mRNA products while emphasizing strict quality control standards, which necessitates sophisticated monitoring tools and systems.
Market Leaders Making an Impact in Messenger Ribonucleic Acid Quality Monitoring
Several prominent companies are leading the way in this market, including F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Danaher Corporation, Lonza Group AG, Eurofins Scientific SE, Agilent Technologies Inc., Illumina Inc., Intertek Group plc, Sartorius AG, Revvity Inc., Bio-Rad Laboratories Inc., WuXi Biologics (Cayman) Inc., QIAGEN N.V., Bio-Techne Corporation, Fujifilm Diosynth Biotechnologies, GenScript Biotech Corporation, Promega Corporation, Takara Bio Inc., Oxford Nanopore Technologies Ltd., Creative Biolabs Inc., Creative Diagnostics, and Jena Bioscience GmbH.
A noteworthy development occurred in September 2024 when Agilent Technologies Inc., a US-based leader in technology and life sciences, acquired BIOVECTRA Inc., a Canadian company specializing in mRNA quality monitoring. This acquisition aims to strengthen Agilent's presence in biopharma services by expanding contract development and manufacturing capabilities for biologics and advanced therapies.
View the full messenger ribonucleic acid quality monitoring market report:
https://www.thebusinessresearchcompany.com/report/global-messenger-ribonucleic-acid-quality-monitoring-market-report
Innovative Trends Shaping the Messenger Ribonucleic Acid Quality Monitoring Industry
Companies in this space are increasingly focusing on creating cutting-edge solutions such as benchtop instruments designed for rapid and precise assessment of mRNA quality attributes. These compact devices enhance laboratory efficiency by providing accessible, fast, and accurate testing without requiring bulky, complex equipment.
For instance, in June 2024, InDevR Inc., a biotechnology and analytical instrumentation firm based in the US, introduced 5'CapQ, a benchtop assay that quickly evaluates critical quality attributes of mRNA vaccines. This test simultaneously measures mRNA integrity and 5' capping efficiency within two hours by selectively capturing capped mRNA molecules and fluorescently labeling their poly(A) tails, ensuring accurate quantification of fully intact mRNA essential for vaccine stability and protein translation. This innovation helps streamline vaccine development by reducing testing times and simplifying procedures.
Analysis of Principal Segments Driving the Messenger Ribonucleic Acid Quality Monitoring Market
This market is segmented based on several criteria that reflect its diversity and application scope:
1) Type: Analytical Instruments, Reagents and Consumables, Software and Services
2) Technology: Liquid Chromatography-Mass Spectrometry (LC-MS), Electrophoresis, Enzyme-Linked Immunosorbent Assay (ELISA), Polymerase Chain Reaction (PCR) Techniques, and other emerging technologies
3) Application: Vaccine Development, Therapeutic mRNA Products, Gene Editing
4) End User: Biopharmaceutical and Biotechnology Companies, Contract Development and Manufacturing Organizations (CDMOs), Contract Research Organizations (CROs) and Analytical Laboratories, Academic and Research Institutes or Centers
Further subdivisions include:
- Analytical Instruments: Benchtop Analyzers, Microfluidic Systems, Spectrophotometers, Capillary Electrophoresis Systems
- Reagents and Consumables: RNA Extraction Kits, Complementary DNA Synthesis Kits, Fluorescent Probes, Quality Control Standards
- Software and Services: Data Analysis Software, Laboratory Information Management Systems, Consulting, Validation, and Training Services
This comprehensive segmentation highlights the intricate components and varied applications that propel the messenger ribonucleic acid quality monitoring market forward, reflecting its critical role in advancing biopharmaceutical innovation.
Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Competitive Analysis: Leading Companies and New Entrants in the Messenger Ribonucleic Acid Quality Monitoring Market here
News-ID: 4308964 • Views: …
More Releases from The Business Research Company
Segment Evaluation and Major Growth Areas in the Personalized Testing and Supple …
The personalized testing and supplements sector is gaining remarkable traction, driven by advancements in technology and a rising consumer focus on tailored health solutions. As more individuals seek customized wellness options, this market is set to experience substantial expansion in the coming years. Here's an in-depth look at its current valuation, key players, significant trends, and the main market segments shaping its future.
Market Valuation and Expansion Forecast for Personalized Testing…
Top Players and Market Competition in the Skin Microbiome Industry
The skin microbiome market is emerging as a significant area of interest due to growing awareness about the critical role of skin health and innovative skincare technologies. As research advances and consumer preferences shift towards more natural and science-backed products, this market is set to undergo substantial growth. Let's explore the current market size, key players, driving factors, and upcoming trends shaping the skin microbiome industry.
Projected Expansion in the Skin…
Key Strategic Developments and Emerging Changes Shaping the Upadacitinib Market …
The upadacitinib market is poised for significant expansion over the coming years, driven by advances in treatment options and increasing awareness of autoimmune diseases. This report delves into the market's current size, key drivers, major players, and the emerging trends shaping its future trajectory.
Steady Growth Expected in Upadacitinib Market Size Through 2029
The market for upadacitinib is projected to reach $2.54 billion by 2029, growing at a robust compound annual…
Analysis of Key Market Segments Driving the Alzheimer's Disease Diagnostic Marke …
The Alzheimer's disease diagnostic sector is rapidly evolving as advancements in technology and healthcare infrastructure open new possibilities for early detection and personalized treatment. With rising awareness and innovative approaches, this market is poised for significant growth in the coming years. Let's explore the current market size, key drivers, leading companies, and emerging trends that are shaping this critical healthcare field.
Projected Market Size and Growth Trends in Alzheimer's Disease Diagnostics…
More Releases for RNA
CD Formulation Launches Custom Circular RNA Synthesis Service to Accelerate RNA …
CD Formulation introduces a customizable circRNA synthesis service, delivering high-quality, stable circRNAs for therapeutics, vaccines, and gene research, supported by advanced design and QC processes.
CD Formulation, a leading provider of advanced small nucleic acid synthesis [https://www.formulationbio.com/nucleic-acid/custom-small-nucleic-acid-synthesis.html] solutions, is proud to announce the launch of its fully customizable circular RNA (circRNA) synthesis service. This new service addresses the growing need for stable, non-immunogenic RNA molecules for therapeutic development, vaccine research, and…
Self-Amplifying RNA Synthesis Market Gains Traction as Biotech Firms Embrace Sca …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the " Self-Amplifying RNA Synthesis Market- (By Product & Service (Products (Enzymes & Reagents, Premade saRNA, Others), Custom Synthesis Services), By Application (Therapeutics Development (Oncology, Infectious Diseases, Others), Biomedical Research), By End-User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Others)), Trends, Industry Competition Analysis, Revenue and Forecast To 2034."
According to the latest research by InsightAce Analytic,…
RNA Extraction and RNA Purification Market: Growth, Trends & Competitive Landsca …
The global RNA Extraction and RNA Purification Market is expected to grow at 6.3% CAGR from 2025 to 2032.
This Market Report is the result of extensive research and analysis conducted by our team of experienced market researchers through -
• 70% efforts of Primary Research
• 15% efforts of Secondary Research
• 15% efforts from the subscription to Paid database providing industry overview, macro and micro economics factors, and financials of private limited…
RNA Targeting Small Molecules Therapeutics Market: Exponential Growth with Risin …
Estimations Predict a CAGR of 29.8% by 2029 in Global RNA Targeting Small Molecules Therapeutics Market Boosted by Precision Medicine, RNA Biomarker Identification and RNA Genetic Manipulation
What Is The Projected Market Size of The Global RNA Targeting Small Molecules Therapeutics Market And Its Growth Rate?
• The market will grow from $6.1 billion in 2024 to $7.87 billion in 2025 at a compound annual growth rate (CAGR) of 28.9%.
• Expected exponential…
Global DNARNA Extraction Kit Market by Type (Cell-free DNA (cfDNA), Sequence-spe …
"DNARNA Extraction Kit Market" is segmented by Company, Region (country), By Type, Application, stakeholders and other participants. This report provides an analysis of revenue and forecast across Type and Application segments for 2023-2032.
The market for DNARNA Extraction Kits has been thoroughly researched via primary and secondary sources to produce this research study. Along with a competitive analysis of the market, segmented by application, type, and geographical trends, it offers a…
Cancer RNA Expression Market to Reap Excessive Revenues by 2028(By sequencing te …
Worldwide cancer is one of the leading cause of death and effective way of treating it still looks unaccomplished in most parts of the world. The factors which influence the successful treatment of cancer are different depending on the stage of diagnosis, treatment availability and availability of trained healthcare professionals coupled with high economic burden of the disease. The gene expression of cancerous cells varies by cancer type and may…
